At the 30th annual ASC Business Meeting, leaders emphasized the transformative potential of AI, patient engagement tools, and noninvasive screenings in gastroenterology. AI pilots improved polyp detection rates by 11%, while patient engagement tech significantly reduced no-shows. Emerging tools like Cytosponge, Cologuard Plus, and the Shield blood test aim to increase screenings but cannot replace colonoscopies. Robotics and disposable scopes promise advancements but remain costly. These innovations are set to improve outcomes and streamline operations in GI care.
Keep Reading
Add A Comment